Medical Transcription Billing Corp (NASDAQ:MTBC) was the recipient of a large drop in short interest in September. As of September 30th, there was short interest totalling 109,200 shares, a drop of 36.6% from the August 30th total of 172,300 shares. Based on an average daily volume of 28,700 shares, the days-to-cover ratio is presently 3.8 days. Approximately 1.8% of the shares of the stock are sold short.
Shares of NASDAQ MTBC traded up $0.16 during mid-day trading on Friday, hitting $3.96. 21,476 shares of the stock traded hands, compared to its average volume of 34,277. The company has a debt-to-equity ratio of 0.09, a current ratio of 2.05 and a quick ratio of 2.01. Medical Transcription Billing has a twelve month low of $3.25 and a twelve month high of $5.65. The company has a market cap of $45.37 million, a PE ratio of -6.71 and a beta of 1.71. The firm has a 50 day simple moving average of $4.20 and a two-hundred day simple moving average of $4.70.
Medical Transcription Billing (NASDAQ:MTBC) last released its quarterly earnings data on Wednesday, August 7th. The technology company reported ($0.19) earnings per share for the quarter, meeting the Thomson Reuters’ consensus estimate of ($0.19). Medical Transcription Billing had a negative return on equity of 17.50% and a negative net margin of 9.21%. The company had revenue of $16.75 million for the quarter, compared to the consensus estimate of $15.33 million. On average, equities research analysts anticipate that Medical Transcription Billing will post -0.55 earnings per share for the current fiscal year.
Separately, National Securities began coverage on Medical Transcription Billing in a report on Thursday. They issued a “buy” rating and a $6.00 target price on the stock.
In other Medical Transcription Billing news, Director John N. Daly sold 8,000 shares of the firm’s stock in a transaction on Friday, August 16th. The stock was sold at an average price of $4.63, for a total value of $37,040.00. Following the sale, the director now owns 124,900 shares of the company’s stock, valued at approximately $578,287. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. In the last ninety days, insiders sold 15,000 shares of company stock worth $65,906. Company insiders own 50.50% of the company’s stock.
Medical Transcription Billing Company Profile
Medical Transcription Billing, Corp. is a healthcare information technology company that provides an integrated suite of Web-based solutions, together with related business services, to healthcare providers practicing in ambulatory care settings. The Company’s offering, PracticePro, allows healthcare practices with the core software and business services on Software-as-a-Service (SaaS) platform.
Featured Story: What is the return on assets formula?
Receive News & Ratings for Medical Transcription Billing Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Transcription Billing and related companies with MarketBeat.com's FREE daily email newsletter.